People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VADovations, Inc. | — | Biotechnology | Series A | $7.0M | $180.8M | 2019 |
Kurt W. Dasse at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kurt W. Dasse on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen M. Prescott | 1 | 2 |
| James W. Long | 1 | 1 |
| Lawrence C. Bruce | 1 | 1 |
| John B. Frick | 1 | 1 |
| Karl E. Nelson | 1 | 1 |
| Timothy E. Pearson | 1 | 1 |
| John W. Long | 1 | 1 |
| Peter E. Dulaney | 1 | 1 |
| Kathryn E. Ingerly | 1 | 1 |
| Karl E. Nelson, R.N., M.B.A. | 1 | 1 |
| Allison E. Petersen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.